ConvaTec stock pre-market at EUR 2.59: plus 0.00 percent
Published on 10/06/2026 at 08:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
ConvaTec stock was at EUR 2.59 pre-market on Lang & Schwarz at 8:20 a.m. CEST on October 6, 2026, unchanged at plus 0.00 percent versus the EUR 2.59 prior close at Lang & Schwarz on October 5, 2026.
Pre-market price
Bid and ask prices were EUR 2.58 and EUR 2.60, respectively. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of ConvaTec stock.
Previous closing price
The prior close at Lang & Schwarz was EUR 2.59 on October 5, 2026.
Share repurchases reported
In an October 5, 2026 announcement, ConvaTec Group Plc said it had purchased 1,328,340 ordinary shares between September 28 and October 2 as part of its buyback program of up to USD 200 million. The purchased shares will be held in treasury. Following the purchases, the company said it held 133,813,259 shares in treasury and had 1,915,976,300 ordinary shares in issue, excluding treasury shares. RNS
Management focus on product development
In an interview published October 5, 2026, CEO Jonny Mason told MedTech Dive that ConvaTec was launching more products in 2026 and increasing investment and manufacturing capacity. The company operates across infusion care, wound care, ostomy care and continence, according to the interview. MedTech Dive
